Ironwood Pharmaceuticals, Inc.
IRWD
$3.58
-$0.09-2.45%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 106.51M | 47.71M | 122.06M | 85.24M | 41.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 106.51M | 47.71M | 122.06M | 85.24M | 41.14M |
| Cost of Revenue | 21.94M | 21.86M | 22.47M | 23.37M | 27.43M |
| Gross Profit | 84.57M | 25.85M | 99.59M | 61.87M | 13.71M |
| SG&A Expenses | 12.03M | 19.10M | 21.91M | 16.80M | 24.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.97M | 40.96M | 44.38M | 40.17M | 51.69M |
| Operating Income | 72.53M | 6.75M | 77.68M | 45.07M | -10.55M |
| Income Before Tax | 65.17M | 455.00K | 68.02M | 37.82M | -36.27M |
| Income Tax Expenses | 24.40M | 2.73M | 27.94M | 14.22M | 1.11M |
| Earnings from Continuing Operations | 40.77M | -2.28M | 40.08M | 23.60M | -37.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.77M | -2.28M | 40.08M | 23.60M | -37.39M |
| EBIT | 72.53M | 6.75M | 77.68M | 45.07M | -10.55M |
| EBITDA | 72.98M | 7.21M | 78.16M | 45.54M | -10.07M |
| EPS Basic | 0.25 | -0.01 | 0.25 | 0.15 | -0.23 |
| Normalized Basic EPS | 0.25 | 0.00 | 0.27 | 0.15 | -0.07 |
| EPS Diluted | 0.24 | -0.02 | 0.23 | 0.14 | -0.23 |
| Normalized Diluted EPS | 0.24 | 0.00 | 0.25 | 0.13 | -0.07 |
| Average Basic Shares Outstanding | 163.45M | 162.44M | 162.22M | 161.72M | 160.97M |
| Average Diluted Shares Outstanding | 166.69M | 162.44M | 177.76M | 176.84M | 160.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |